
    
      The investigators randomized 30 women with OAB, in two groups: G I (15 patients) received 30
      minutes TPTNS, three times a week; GII (15 patients) received TPTNS plus Low dose trospium
      chloride (20 mg once daily); all for 8 weeks. Patients were evaluated using Overactive
      Bladder Symptom Score questionnaire (OABSS), Incontinence Impact Questionnaire-short form 7
      (IIQ-7), 3 day voiding diary and urodynamics at weeks 0 and 8.
    
  